Risk factors of daptomycin overexposure: a case-control study
Antimicrobial Agents and Chemotherapy · 2025
DOI: 10.1128/aac.01139-25 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Clotilde Vellat und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire de Biométrie et Biologie Evolutive, UMR 5558, CNRS & Université Lyon 1, Villeurbanne, France. Hauptthemen laut MEDLINE: Daptomycin, Anti-Bacterial Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In our institution, therapeutic drug monitoring of daptomycin is performed routinely and cases of high trough concentrations have been observed in patients without known risk factors. The aim of this study was to identify risk factors of daptomycin overexposure. We performed a case-control study of daptomycin overexposure in patients who received daptomycin between 2013 and 2021. Cases and controls were defined as patients with trough concentration (Cmin) ≥60 mg/L and Cmin
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratoire de Biométrie et Biologie Evolutive, UMR 5558, CNRS & Université Lyon 1, Villeurbanne, France.
- Hospices Civils de Lyon, Groupement Hospitalier Nord, Service de Pharmacie, Lyon, France.
- Univ Lyon, Université Claude Bernard Lyon 1, Facultés de Médecine et de Pharmacie de Lyon, Lyon, France.
- Hospices Civils de Lyon, Groupement Hospitalier Sud, Service de Biochimie et Biologie Moléculaire, UM Pharmacologie-Toxicologie, Lyon, France.
- Hospices Civils de Lyon, Groupement Hospitalier Nord, Hôpital de la Croix-Rousse, Service des Maladies Infectieuses et Tropicales, Centre de Référence pour la Prise en Charge des Infections Ostéo-Articulaires Complexes…
ORCID-Profile: Romain Garreau, Sylvain Goutelle
Zitieren
APA
Vellat, C., Garreau, R., Millet, A., Piron, C., Bourguignon, L., Roux, S., Ferry, T., Goutelle, S., & Lyon Bone and Joint Infection Study Group (2025). Risk factors of daptomycin overexposure: a case-control study. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01139-25
Vancouver
Vellat C, Garreau R, Millet A, Piron C, Bourguignon L, Roux S, et al. Risk factors of daptomycin overexposure: a case-control study. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.01139-25
BibTeX
@article{Vellat2025,
author = {Vellat, Clotilde and Garreau, Romain and Millet, Aurélien and Piron, Catherine and Bourguignon, Laurent and Roux, Sandrine and Ferry, Tristan and Goutelle, Sylvain and Lyon Bone and Joint Infection Study Group, Lyon Bone and Joint Infection Study Group},
title = {Risk factors of daptomycin overexposure: a case-control study},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2025},
doi = {10.1128/aac.01139-25}
}
EUVIMED